Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Diprophylline (substance) |
Is a |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ambuphylline (substance) |
Is a |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Leukotriene receptor antagonist |
Is a |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline (substance) |
Is a |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline (substance) |
Is a |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline 250mg/2cc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline 160mg/15ml elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline 100mg/15mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline 200mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 50mg/1mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely diprophylline 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 400mg/10 mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 800 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 100mg/5mL oral liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely guaifenesin 675 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 575 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely guaifenesin 600 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 100mg/100mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 100mg/100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 100mg/100mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 100mg/50mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline + guaifenesin 200mg/100mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 600mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing diprophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing diprophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parenteral dyphylline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline+guaifenesin 100mg/100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Siltussin sa 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 1200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 300mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 600mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Respiratory smooth muscle relaxant (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Substance with 5-lipoxygenase inhibitor mechanism of action (substance) |
Is a |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xanthine bronchodilator |
Is a |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Zileuton |
Is a |
False |
Respiratory smooth muscle relaxant |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|